about
Generation of Brain Microvascular Endothelial-Like Cells from Human Induced Pluripotent Stem Cells by Co-Culture with C6 Glioma CellsHighly efficient biallelic genome editing of human ES/iPS cells using a CRISPR/Cas9 or TALEN system.Prediction of interindividual differences in hepatic functions and drug sensitivity by using human iPS-derived hepatocytes.HHEX promotes hepatic-lineage specification through the negative regulation of eomesodermin.Efficient generation of functional hepatocytes from human embryonic stem cells and induced pluripotent stem cells by HNF4α transduction.Generation of enterocyte-like cells from human induced pluripotent stem cells for drug absorption and metabolism studies in human small intestineLong-term self-renewal of human ES/iPS-derived hepatoblast-like cells on human laminin 111-coated dishes.Prediction of Differentiation Tendency Toward Hepatocytes from Gene Expression in Undifferentiated Human Pluripotent Stem Cells.Generation of a bile salt export pump deficiency model using patient-specific induced pluripotent stem cell-derived hepatocyte-like cellsHuman induced-pluripotent stem cell-derived hepatocyte-like cells as an in vitro model of human hepatitis B virus infection.Modeling of drug-mediated CYP3A4 induction by using human iPS cell-derived enterocyte-like cells.Hepatic maturation of human iPS cell-derived hepatocyte-like cells by ATF5, c/EBPα, and PROX1 transduction.Laminin 411 and 511 promote the cholangiocyte differentiation of human induced pluripotent stem cells.Efficient Engraftment of Human Induced Pluripotent Stem Cell-Derived Hepatocyte-Like Cells in uPA/SCID Mice by Overexpression of FNK, a Bcl-xL Mutant Gene.Hepatitis C virus-induced innate immune responses in human iPS cell-derived hepatocyte-like cells.Inhibition of CRISPR/Cas9-Mediated Genome Engineering by a Type I Interferon-Induced Reduction in Guide RNA Expression.CCAAT/enhancer binding protein-mediated regulation of TGFβ receptor 2 expression determines the hepatoblast fate decision.Generation of Optogenetically Modified Adenovirus Vector for Spatiotemporally Controllable Gene Therapy.Isolation and expansion of human pluripotent stem cell-derived hepatic progenitor cells by growth factor defined serum-free culture conditions.Human ESC/iPSC-Derived Hepatocyte-like Cells Achieve Zone-Specific Hepatic Properties by Modulation of WNT Signaling.Hepatocyte Nuclear Factor 4 Alpha Promotes Definitive Endoderm Differentiation from Human Induced Pluripotent Stem Cells.Transplantation of a human iPSC-derived hepatocyte sheet increases survival in mice with acute liver failure.Optimal human iPS cell culture method for efficient hepatic differentiationEfficient Generation of Small Intestinal Epithelial-like Cells from Human iPSCs for Drug Absorption and Metabolism Studies.Tolloid-Like 1 Negatively Regulates Hepatic Differentiation of Human Induced Pluripotent Stem Cells Through Transforming Growth Factor Beta SignalingComparison of commercially available media for hepatic differentiation and hepatocyte maintenance[Pharmaceutical Research on Liver Diseases Using iPS Cell and Genome Editing Technologies]Pharmaceutical Research for Inherited Metabolic Disorders of the Liver Using Human Induced Pluripotent Stem Cell and Genome Editing TechnologiesEstablishment of SLC15A1/PEPT1-Knockout Human-Induced Pluripotent Stem Cell Line for Intestinal Drug Absorption StudiesModeling of Hepatic Drug Metabolism and Responses in CYP2C19 Poor Metabolizer Using Genetically Manipulated Human iPS cellsGeneration of Human iPSC-Derived Intestinal Epithelial Cell Monolayers by CDX2 Transduction
P50
Q28548080-7F79E291-CA18-4B3A-9B04-8E243F6EDB7CQ33701667-3494F5AB-5173-4C33-B401-066EB0F34AF9Q34601581-DA9403E9-6D3D-41D8-975A-6971435DACE6Q35126482-EBABC49A-A56A-40D4-BBFF-1FE2BC82EDE9Q35665145-0B6707D3-D6C3-4D58-BCAE-D046D749746BQ36272752-A15B1A81-540D-4EBE-9317-FD79E3FEED82Q37360935-ABE9D7E1-C73E-443E-BAFA-71AAD7E6DBBDQ37513377-C76FC372-AD79-4F86-8402-6B59EC3448FDQ37620655-1497B88D-DBF4-4B65-8016-6A257EE00D8DQ37736696-5A3F7B6E-2B77-40C9-9E79-C1EC173348C8Q38293285-0E8941DC-1589-417E-8C0A-52494C139480Q38294717-71FBD858-2333-4F1B-A048-094B1C03193AQ38776304-60CD4AE9-8AAE-4824-86D3-8C9964AA1A7AQ38997397-02E54D2B-1199-418F-877B-2E2A1642BCC4Q40046934-7E669E80-911C-4126-9488-8D1CE85DC26FQ40312489-233256D5-A9EB-47B2-9153-1F7F721AF6A6Q47951369-D5FEE004-9CA0-49DC-818E-2D0A64C57F5AQ48254450-94472319-B58C-446C-B7F3-F99D775759D2Q50884321-0C561584-1E2B-4636-8A8B-F62FA1F78DF8Q50893427-719C80E9-518B-4C00-91B7-C9CD391C68E4Q51070593-B3108975-1BF1-473E-B9AD-9E126E990806Q51557552-F0343BCF-04CA-4835-A42B-F39793AF6F5DQ57070254-BB2CD8AD-C1F8-4101-B84A-A1C709DE91B7Q64993650-DC77AE10-851B-44C2-AE92-315E714E5874Q89560945-598919BC-BE83-4C9D-AD0E-88B20455700EQ89919297-2DB13FCE-89A5-411A-B554-D98C6A0AE58BQ90467030-A421D1A8-6BEE-4CC3-B76B-82737CE2CC36Q92086356-2BD7034E-24E1-46BA-BF90-7EF15B015FD6Q92345073-82A7F7F0-A2B4-4305-AB9D-C4F40BCB960EQ92953361-CEF39D1F-704D-45AD-AEA2-6D50BCAEC0FCQ92954289-FC38408F-D3DA-4979-960A-99780D63DF60
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Kazuo Takayama
@ast
Kazuo Takayama
@en
Kazuo Takayama
@es
Kazuo Takayama
@nl
type
label
Kazuo Takayama
@ast
Kazuo Takayama
@en
Kazuo Takayama
@es
Kazuo Takayama
@nl
prefLabel
Kazuo Takayama
@ast
Kazuo Takayama
@en
Kazuo Takayama
@es
Kazuo Takayama
@nl
P108
P106
P31
P496
0000-0002-1132-2457